Clinical Trials in Pittsburgh

Showing 7221-7240 of 21,047 trials

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)

NCT03675126

The purpose of this extension study is to evaluate the safety, tolerability, and pharmacokinetics of repeat administrations of SRP-5051 (vesleteplirsen) in participants with Duchenne muscular dystrophy (DMD) who participated in studies of SRP-5051.

Muscular Dystrophy, Duchenne

Sarepta Therapeutics, Inc.15 participantsStarted Dec 2018

Hartford, Connecticut, United States • Gulf Breeze, Florida, United States • Atlanta, Georgia, United States +5 more locations

TERMINATEDPhase 1< 1 mile

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

NCT03783403

The purpose of this study is to evaluate the safety, tolerability, and preliminary clinical activity of CC-95251 as a single agent and in combination with cetuximab and rituximab in participants with advanced solid and hematologic cancers.

Neoplasms

Celgene206 participantsStarted Mar 2019

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Sacramento, California, United States +28 more locations

An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Find Trials by Condition in Pittsburgh

Epigenetic Effects on Traumatic Brain Injury Recovery

Randomized Controlled Trial for Vestibular Treatment in Concussion

Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity

Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer

Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors

Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

AI ENRICH - AI Detection of ICH

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation

A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

A Safety and Efficacy Study in Patients With Gastric Cancer

Pilot Trial of the RUBI Program for Autistic Adults

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload